Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | affects expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | Estradiol affects the expression of GLT8D2 mRNA | CTD | PMID:22574217 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Glt8d2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GLT8D2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GLT8D2 mRNA | CTD | PMID:33387578 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | Glt8d2 (Mus musculus) | 6480464 | tetrabromobisphenol A results in decreased expression of GLT8D2 mRNA | CTD | PMID:25172293 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GLT8D2 mRNA | CTD | PMID:36041667 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Glt8d2 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of GLT8D2 mRNA | CTD | PMID:28973697 | aldehydo-D-glucose | multiple interactions | ISO | Glt8d2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of GLT8D2 mRNA | CTD | PMID:37567420 | all-trans-retinoic acid | increases expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of GLT8D2 mRNA | CTD | PMID:21934132 | belinostat | decreases expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | belinostat results in decreased expression of GLT8D2 mRNA | CTD | PMID:27188386 | benzo[a]pyrene | multiple interactions | ISO | Glt8d2 (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of GLT8D2 mRNA] | CTD | PMID:22228805 | benzo[a]pyrene | affects methylation | ISO | GLT8D2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of GLT8D2 5' UTR and Benzo(a)pyrene affects the methylation of GLT8D2 promoter | CTD | PMID:27901495 | benzo[e]pyrene | decreases methylation | ISO | GLT8D2 (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of GLT8D2 intron | CTD | PMID:30157460 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GLT8D2 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | Glt8d2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of GLT8D2 mRNA | CTD | PMID:32156529 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GLT8D2 mRNA | CTD | PMID:36041667 | bisphenol A | multiple interactions | ISO | GLT8D2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of GLT8D2 gene | CTD | PMID:31601247 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GLT8D2 mRNA | CTD | PMID:36041667 | cadmium atom | multiple interactions | ISO | GLT8D2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GLT8D2 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | GLT8D2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GLT8D2 mRNA | CTD | PMID:35301059 | calcitriol | decreases expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of GLT8D2 mRNA | CTD | PMID:26485663 | CGP 52608 | multiple interactions | ISO | GLT8D2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to GLT8D2 gene] | CTD | PMID:28238834 | D-glucose | multiple interactions | ISO | Glt8d2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of GLT8D2 mRNA | CTD | PMID:37567420 | dorsomorphin | multiple interactions | ISO | GLT8D2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of GLT8D2 mRNA | CTD | PMID:29803840 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of GLT8D2 mRNA | CTD | PMID:29391264 | entinostat | increases expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | entinostat results in increased expression of GLT8D2 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | GLT8D2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLT8D2 mRNA | CTD | PMID:27188386 | fructose | multiple interactions | ISO | Glt8d2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of GLT8D2 mRNA | CTD | PMID:37567420 | fulvestrant | multiple interactions | ISO | GLT8D2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of GLT8D2 gene | CTD | PMID:31601247 | glucose | multiple interactions | ISO | Glt8d2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of GLT8D2 mRNA | CTD | PMID:37567420 | glyphosate | multiple interactions | ISO | Glt8d2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of GLT8D2 mRNA | CTD | PMID:37567420 | hydroquinone O-beta-D-glucopyranoside | decreases expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | Arbutin results in decreased expression of GLT8D2 mRNA | CTD | PMID:17103032 | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of GLT8D2 mRNA | CTD | PMID:28801915 | methapyrilene | decreases methylation | ISO | GLT8D2 (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of GLT8D2 intron | CTD | PMID:30157460 | methylmercury chloride | decreases expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of GLT8D2 mRNA | CTD | PMID:28001369 | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of GLT8D2 mRNA | CTD | PMID:28801915 | nickel atom | decreases expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | Nickel results in decreased expression of GLT8D2 mRNA | CTD | PMID:24768652 and PMID:25583101 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of GLT8D2 mRNA | CTD | PMID:33387578 | SB 431542 | multiple interactions | ISO | GLT8D2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of GLT8D2 mRNA | CTD | PMID:25895662 | sodium arsenite | increases expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of GLT8D2 mRNA | CTD | PMID:22714537 | temozolomide | increases expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of GLT8D2 mRNA | CTD | PMID:31758290 | testosterone | increases expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | Testosterone results in increased expression of GLT8D2 mRNA | CTD | PMID:33359661 | tetrachloromethane | affects expression | ISO | Glt8d2 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of GLT8D2 mRNA | CTD | PMID:17484886 | tetraphene | decreases expression | ISO | Glt8d2 (Mus musculus) | 6480464 | benz(a)anthracene results in decreased expression of GLT8D2 mRNA | CTD | PMID:26377693 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of GLT8D2 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of GLT8D2 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | GLT8D2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLT8D2 mRNA | CTD | PMID:27188386 | triclosan | increases expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | Triclosan results in increased expression of GLT8D2 mRNA | CTD | PMID:30510588 | triptonide | increases expression | ISO | Glt8d2 (Mus musculus) | 6480464 | triptonide results in increased expression of GLT8D2 mRNA | CTD | PMID:33045310 | valproic acid | affects expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of GLT8D2 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of GLT8D2 mRNA | CTD | PMID:19101580 more ... | valproic acid | multiple interactions | ISO | GLT8D2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLT8D2 mRNA | CTD | PMID:27188386 | valproic acid | decreases expression | ISO | GLT8D2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of GLT8D2 mRNA | CTD | PMID:23179753 more ... | vorinostat | multiple interactions | ISO | GLT8D2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLT8D2 mRNA | CTD | PMID:27188386 | |